Translating Nature’s Library: The Bryostatins and Function‐Oriented Synthesis

Israel Journal of Chemistry - Tập 51 Số 3-4 - Trang 453-472 - 2011
Paul A. Wender1, Brian A. Loy2, Adam J. Schrier2
1Department of Chemistry Department of Chemical and Systems Biology Stanford University Stanford, CA 94305, USA.
2Department of Chemistry, Department of Chemical and Systems Biology, Stanford University, Stanford, CA 94305, USA phone: +1 650 723-0208 fax: +1 650 725-0259

Tóm tắt

Abstract

We review in part our computational, design, synthesis, and biological studies on a remarkable class of compounds and their designed analogs that have led to preclinical candidates for the treatment of cancer, a first‐in‐class approach to Alzheimer’s disease, and a promising strategy to eradicate HIV/AIDS. Because these leads target, in part, protein kinase C (PKC) isozymes, they have therapeutic potential even beyond this striking set of therapeutic indications. This program has given rise to new synthetic methodology and represents an increasingly important direction of synthesis focused on achieving function through synthesis‐informed design (function‐oriented synthesis).

Từ khóa


Tài liệu tham khảo

For pertinent discussions see:

10.1038/460197a

10.1126/science.1962206

10.1002/ange.200806086

10.1002/anie.200806086

Sheldon R. A., 1992, Chem. Ind., 903

10.1351/pac200072071233

Anastas P. T., 1998, Green Chemistry Theory and Practice

 

10.1021/cr900019j

10.1021/cb100105c

Mann J., 2003, Nat. Rev., 143

 

10.2174/1570163043484888

10.1021/ar700155p

10.1021/mp800043n

10.1002/ange.200904761

10.1002/anie.200904761

For some recent examples see:

10.1002/ejoc.201001450

10.1021/jm100243n

10.1073/pnas.0915125107

10.1016/j.bmc.2008.12.042

10.1021/jo802269q

10.1021/ja101811x

10.1016/j.bmcl.2004.08.068

10.1021/ja904179f

10.1021/ja030496v

10.1021/ja808447r

10.1016/B978-012072651-6/50013-9

Wender P. A., 2007, Drug Discovery Research: New Frontiers in the Post‐Genomic Era, 127

10.1021/ja9727631

10.1002/ajh.21449

 

10.1016/j.tibs.2008.11.006

10.1002/ardp.200900050

10.1016/j.nbd.2009.02.003

10.1016/j.pharmthera.2010.03.001

Mehla R., 2010, PLoS ONE, 5

 

10.1073/pnas.83.12.4214

10.1073/pnas.85.19.7197

Suffness M., 1995, Taxol: Science and Applications

10.1007/s00442-004-1487-5

 

10.1021/ja805037p

10.1126/science.1099191

10.1021/ja000563a

10.1002/ange.201006637

10.1002/anie.201006637

 

10.1038/nchembio0705-74

10.1002/ange.200703073

10.1002/anie.200703073

10.1021/ar100014h

10.1021/ja039714a

10.1021/jm901098m

10.1021/ja9706256

10.1021/np9604386

10.1038/227962a0

10.1021/ja00388a092

 

10.1097/00001813-200208000-00001

10.1021/np040031y

 

10.1073/pnas.0805952105

10.1073/pnas.0907842106

10.1016/j.copbio.2010.09.018

 

For current clinical information see:http://clinicaltrials.gov;

10.1081/CNV-120025095

10.1016/j.exphem.2008.09.008

10.1124/mol.61.4.759

For reviews of PKC see:

10.1021/cr0002801

10.1002/iub.122

10.1021/np50077a004

10.1016/S1389-0344(03)00075-3

 

10.1016/j.chembiol.2004.08.018

10.1021/np060361d

For recent reviews of synthetic approaches to the bryostatins see:

10.1039/b009211h

10.1002/asia.200900634

10.1021/ja00176a058

 

10.1002/(SICI)1521-3757(19980904)110:17<2526::AID-ANGE2526>3.0.CO;2-B

10.1002/(SICI)1521-3773(19980918)37:17<2354::AID-ANIE2354>3.0.CO;2-9

10.1021/ja990860j

10.1139/v91-126

10.1002/1521-3757(20000703)112:13<2376::AID-ANGE2376>3.0.CO;2-5

10.1002/1521-3773(20000703)39:13<2290::AID-ANIE2290>3.0.CO;2-6

10.1021/ol061626i

10.1038/nature07543

10.1021/ja105129p

10.1021/ja110198y

 

10.1021/ja8022169

10.1021/ol8027253

10.1021/ol900585t

10.1002/anie.201001200

 

10.1016/j.tetlet.2008.08.075

10.1016/j.tetlet.2006.01.097

10.1351/pac199668030715

10.1039/c39890001308

 

10.1021/ol0483044

10.1021/jo0495081

 

10.1021/ol901096d

10.1021/ol052976s

10.1021/ol015551o

10.1016/S0040-4039(01)00841-3

Pettit G. R., 1992, Anti‐Cancer Drug Des., 7, 101

10.1073/pnas.95.12.6624

For additional and impressive examples of this dioxane design opportunity see:

10.1021/ol060014v

10.1002/chem.201002402

10.1021/jm901215m

10.1021/ja00070a010

10.1021/ja00832a031

10.1021/ol0258785

10.1021/jo00354a003

10.1021/jo00170a070

10.1246/bcsj.52.1989

10.1016/0040-4020(95)01080-7

B. Lippa Ph.D. Dissertation Stanford University Stanford CA 1999.

10.1021/ja027509

10.1021/ja00071a074

10.1021/ol0272390

10.1021/ja00253a051

10.1016/S0040-4039(98)01955-8

10.1021/ol0504650

10.1021/ol0618149

10.1038/nrc2168

 

10.1021/ol060457z

P. A. Wender J. L. Baryza S. E. Brenner B. A. DeChristopher B. A. Loy A. J. Schrier V. A. Verma Proc. Natl. Acad. Sci.USA2011 in press.

 

S. E. Brenner Ph.D. Dissertation Stanford University Stanford CA 2004;

J. L. Baryza Ph.D. Dissertation Stanford University Stanford CA 2005.

10.1021/ol801235h

Prepared in one step from ethyl acetoacetate.

Prepared in 4 steps and ∼95 % ee from acrolein and benzyl alcohol using an asymmetric allylation to set the C3 configuration.

10.1021/ja00219a035

10.1039/p19750001574

 

10.1016/S0092-8674(00)81763-8

10.1016/j.chembiol.2004.06.014

For applications of ring closing metathesis processes in total synthesis see:

10.1002/ange.200500369

10.1002/anie.200500369

10.1002/ange.200600641

10.1002/anie.200600641

10.1016/j.tetlet.2006.01.097

10.1021/ja067305j

10.1021/ja046385t

10.1021/ja8015632

For recent reviews of applications of the Prins reaction and cyclization see:

10.2174/138527207781024067

10.1016/j.tet.2009.10.069

10.1002/hlca.19790620817

 

10.1016/S0040-4039(00)91736-2

10.1021/jo00034a003

10.1021/ol025645d

 

10.1021/ol050511w

10.1021/ol050512o

10.1016/j.tetlet.2006.09.094

10.1016/S0040-4039(01)91347-4

10.1016/S0040-4039(97)00345-6

10.1016/S0040-4039(00)60618-4

For application of this reagent in bryostatin and analog synthesis see refs. [36] [38] and [42];

10.1021/ol902778y

10.1021/ja710080q

10.1002/ange.200800386

10.1002/anie.200800386

10.1021/ja805187p

For several recent examples see:

10.1021/ol9022062

10.1021/ja904604x

10.1016/j.tet.2009.11.054

10.1021/ja1009579

10.1002/anie.201002809